Related Articles
Anti‑PD‑1/PD‑L1 and anti‑CTLA‑4 associated checkpoint inhibitor pneumonitis in non‑small cell lung cancer: Occurrence, pathogenesis and risk factors (Review)
Immune checkpoint inhibitors in metastatic melanoma therapy (Review)
Immunotherapy in malignant peritoneal mesothelioma (Review)
Liquid biopsy for lung cancer immunotherapy (Review)
Neoantigens and their potential applications in tumor immunotherapy (Review)